ASCAT 2025 Programme

Sickle Cell Disease: Defining Meaningful Endpoints in SCD Clinical Trials

Friday, October 3, 2025

9:15 AM - 10:15 AM

Main Plenary Hall - Rooms 8 & 11

Overview

Chair:
Biree Andemariam
Speakers:
Miguel Abboud (Lebanon)
Andrew Campbell (US)
Mohamed Yassin (Qatar)
Main Plenary Hall - Rooms 8 & 11

Presenters

Agenda Item Image

Prof. Biree Andemariam

Professor Of Medicine

University Of Connecticut Health

Session Chair

Dr Miguel Abboud

Professor And Chairman

AUBMC

Sickle Cell Disease : Defining Meaningful Endpoints in SCD Clinical Trials

Agenda Item Image

Dr Andrew Campbell

Director, Comprehensive Sickle Cell Disease Program

Childrens National Hospital

Sickle Cell Disease : Defining Meaningful Endpoints in SCD Clinical Trials

Prof. Mohamed Yassin

Senior Consultant

HMC- Qatar University

Sickle Cell Disease : Defining Meaningful Endpoints in SCD Clinical Trials

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript